Literature DB >> 15538930

Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice.

Martin Schlumberger1, Furio Pacini, Wilmar M Wiersinga, Antony Toft, Johannes W A Smit, Franco Sanchez Franco, Peter Lind, Edward Limbert, Barbara Jarzab, François Jamar, Leonidas Duntas, Ohad Cohen, Gertrud Berg.   

Abstract

As differentiated (follicular and papillary) thyroid cancer (DTC) may recur years after initial treatment, follow-up of patients with DTC is long term. However, this population has changed, with more individuals being discovered at an earlier stage of disease, so that previous follow-up protocols based mostly on data from high-risk patients no longer apply. We have proposed, in a previous issue of this Journal, an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies. We report here the case of a paradigmatic patient with papillary thyroid carcinoma, with the goal of illustrating the benefits of applying this algorithm in routine clinical practice. We also offer expanded and additional comments on various issues in the management of DTC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538930     DOI: 10.1530/eje.0.1510539

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  18 in total

1.  On-site ultrasound-guided localization for impalpable nodal recurrences in papillary thyroid carcinoma patients.

Authors:  Kuk-Jin Kim; Bup-Woo Kim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  J Korean Surg Soc       Date:  2013-08-26

2.  2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.

Authors:  L Leenhardt; M F Erdogan; L Hegedus; S J Mandel; R Paschke; T Rago; G Russ
Journal:  Eur Thyroid J       Date:  2013-09-05

3.  Papillary thyroid carcinoma presenting as a solitary soft tissue arm metastasis in an elderly hyperthyroid patient. Case report and review of the literature.

Authors:  Angela Pucci; Monica Suppo; Giovanni Lucchesi; Angela Celeste; Laura Viberti; Riccardo Pellerito; Mauro Papotti
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

4.  Clinical impact of cervical lymph node involvement and central neck dissection in patients with papillary thyroid carcinoma: a retrospective analysis of 368 cases.

Authors:  Alexandre Bozec; Olivier Dassonville; Emmanuel Chamorey; Gilles Poissonnet; Anne Sudaka; Isabelle Peyrottes; Francette Ettore; Juliette Haudebourg; Françoise Bussière; Danielle Benisvy; Pierre-Yves Marcy; Jean Louis Sadoul; Paul Hofman; Sandra Lassale; Jacques Vallicioni; François Demard; José Santini
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-05-24       Impact factor: 2.503

Review 5.  Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer.

Authors:  Chao Ma; Jiawei Xie; Wanxia Liu; Guoming Wang; Shuyao Zuo; Xufu Wang; Fengyu Wu
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

6.  Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine.

Authors:  Denise P Momesso; Fernanda Vaisman; Samantha P Yang; Daniel A Bulzico; Rossana Corbo; Mario Vaisman; R Michael Tuttle
Journal:  J Clin Endocrinol Metab       Date:  2016-03-29       Impact factor: 5.958

7.  Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study.

Authors:  L A Tortajada-Genaro; M P Cózar; J L Moreno Frigols; C Romero de Avila
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

8.  Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen.

Authors:  S Kohlfuerst; I Igerc; M Lobnig; H J Gallowitsch; I Gomez-Segovia; S Matschnig; J Mayr; P Mikosch; M Beheshti; P Lind
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-24       Impact factor: 9.236

9.  The contributions of gamma probe to lesion detectability and surgical safety in recurrent thyroid cancer at risk.

Authors:  Salih Sinan Gültekin; Güleser Saylam; Tuncay Delibaşı; Hakan Korkmaz
Journal:  Mol Imaging Radionucl Ther       Date:  2013-08-01

10.  Thyroglobulin Measurement in Needle Aspiration for Detection of Recurrences and Neck Metastases in Patients with Differentiated Thyroid Carcinoma: Significance of Anti-Tg Antibodies.

Authors:  Ivan Blažeković; Matija Romić; Marija Bosak Butković; Ines Šiško Markoš; Vedrana Gladić Nenadić; Valentina Vidranski; Petra Petranović Ovčariček; Dražena Krilić; Tea Varjačić; Josip Staničić; Roko Granić; Marija Punda; Ivan Mihaljević; Tomislav Jukić; Maja Franceschi
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.